...
首页> 外文期刊>Cellular and molecular biology >The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.
【24h】

The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.

机译:4'-乙炔基-2-氟-2'-脱氧腺苷的糖环构象及其对HIV逆转录酶聚合酶活性位点的识别。

获取原文
获取原文并翻译 | 示例
           

摘要

4' Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is the most potent inhibitor of HIV reverse transcriptase (RT). We have recently named EFdA a Translocation Defective RT Inhibitor (TDRTI) because after its incorporation in the nucleic acid it blocks DNA polymerization, primarily by preventing translocation of RT on the template/primer that has EFdA at the 3'-primer end (T/PEFdA). The sugar ring conformation of EFdA may also influence RT inhibition by a) affecting the binding of EFdA triphosphate (EFdATP) at the RT active site and/or b) by preventing proper positioning of the 3'-OH of EFdA in T/PEFdA that is required for efficient DNA synthesis. Specifically, the North (C2'-exo/C3'-endo), but not the South (C2'-endo/C3'-exo) nucleotide sugar ring conformation is required for efficient binding at the primer-binding and polymerase active sites of RT. In this study we use nuclear magnetic resonance (NMR) spectroscopy experiments to determine the sugar ring conformation of EFdA. We find that unlike adenosine nucleosides unsubstituted at the 4'-position, the sugar ring of EFdA is primarily in the North conformation. This difference in sugar ring puckering likely contributes to the more efficient incorporation of EFdATP by RT than dATP. In addition, it suggests that the 3'-OH of EFdA in T/PEFdA is not likely to prevent incorporation of additional nucleotides and thus it does not contribute to the mechanism of RT inhibition. This study provides the first insights into how structural attributes of EFdA affect its antiviral potency through interactions with its RT target.
机译:4'乙炔基-2-氟-2'-脱氧腺苷(EFdA)是最有效的HIV逆转录酶(RT)抑制剂。我们最近将EFdA称为易位缺陷RT抑制剂(TDRTI),因为它在核酸中掺入后会阻止DNA聚合,主要是通过防止RT在3'引物末端具有EFdA的模板/引物上易位(T / PEFdA)。 EFdA的糖环构象也可能通过以下方式影响RT抑制:a)影响EFdA三磷酸酯(EFdATP)在RT活性位点的结合,和/或b)通过阻止EFdA的3'-OH在T / PEFdA中的正确定位来影响RT抑制有效合成DNA是必需的。具体来说,北部(C2'-exo / C3'-endo)而不是南部(C2'-endo / C3'-exo)核苷酸糖环构象是在以下引物结合和聚合酶活性位点有效结合所必需的RT。在这项研究中,我们使用核磁共振(NMR)光谱实验来确定EFdA的糖环构象。我们发现,与在4'-位置未取代的腺苷核苷不同,EFdA的糖环主要位于North构象。糖环起皱的这种差异可能是由于rtd的EFdATP比dATP的结合更有效。另外,这表明T / PEFdA中的EFdA的3'-OH不太可能阻止其他核苷酸的掺入,因此它对RT抑制的机理没有贡献。这项研究提供了关于EFdA的结构属性如何通过与其RT靶标相互作用而影响其抗病毒效力的初步见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号